LCTX · Company research
Lineage Cell Therapeutics, Inc. (LCTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (AMEX: LCTX) Share Price, LCTX Stock News, LCTX Share Price & Updates - kalkine.ca | (AMEX: LCTX) Share Price, LCTX Stock News, LCTX Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Oct 15, 2026 | neutral | 0 | 0.6 |
| LCTX Dec 2026 2.000 call (LCTX261218C00002000) stock price, news, quote and history - Yahoo Finance UK | LCTX Dec 2026 2.000 call (LCTX261218C00002000) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Sep 30, 2026 | neutral | 0 | 0.6 |
| Lineage Cell Therapeutics (LCTX) Slips to $1.02 as Shares Drift Toward Lower Support - TWAP Entry - dars.gov.et | Lineage Cell Therapeutics (LCTX) Slips to $1.02 as Shares Drift Toward Lower Support - TWAP Entry dars.gov.et | View source ↗ | dars.gov.et | Sep 21, 2026 | neutral | 0 | 0.6 |
| A cell-making system gets a U.S. patent expected to run through 2043 from Lineage Cell Therapeutics - Stock Titan | A cell-making system gets a U.S. patent expected to run through 2043 from Lineage Cell Therapeutics Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| Lineage Cell Therapeutics (LCTX) Stock Faces Cash Burn Despite Paper Profit - Simply Wall Street | Lineage Cell Therapeutics (LCTX) Stock Faces Cash Burn Despite Paper Profit Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
| Lineage CEO Brian Culley set for B. Riley healthcare summit - Stock Titan | Lineage CEO Brian Culley set for B. Riley healthcare summit Stock Titan | View source ↗ | Stock Titan | Jul 6, 2026 | neutral | 0 | 0.6 |
| LCTX Edges Higher As Traders Focus On Tight Range Break - timothysykes.com | LCTX Edges Higher As Traders Focus On Tight Range Break timothysykes.com | View source ↗ | timothysykes.com | Jun 26, 2026 | neutral | 0 | 0.6 |
| LCTX Holds Tight Range As Traders Eye Next Break - StocksToTrade | LCTX Holds Tight Range As Traders Eye Next Break StocksToTrade | View source ↗ | StocksToTrade | Jun 26, 2026 | neutral | 0 | 0.6 |
| LCTX Forecast — Price Target — Prediction for 2027 - TradingView | LCTX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage - Yahoo Finance | Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage Yahoo Finance | View source ↗ | Yahoo Finance | Jun 18, 2026 | neutral | 0 | 0.6 |
| How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets - Yahoo Finance | How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets Yahoo Finance | View source ↗ | Yahoo Finance | Jun 4, 2026 | neutral | 0 | 0.6 |
| Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow - Seeking Alpha | Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | May 7, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 10, 2024 | neutral | 0 | 0.6 |
| LCTX: Lineage Cell Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | LCTX: Lineage Cell Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Aug 1, 2019 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.